Skip to main content

Table 2 Baseline prevalence of comorbidity among lung cancer patients and mean survival days by comorbidity and stage of lung cancer at diagnosis

From: Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes

Comorbidity Stage P-value
I II III IV
N = 214 N = 104 N = 399 N = 378
  % Mean % Mean % Mean % Mean  
Other cancer          
 No 91.6 1235 96.2 1072 94.7 718 94.4 467 -
 Yes 8.4 1157 3.8 334 5.3 829 5.6 853 0.093
Tuberculosis          
 No 92.5 1247 89.4 1075 90.2 743 89.4 500 -
 Yes 7.5 1002 10.6 774 9.8 553 10.6 395 0.004
COPD          
 No 92.1 1213 94.2 1038 95.5 726 96.3 491 -
 Yes 7.9 1408 5.8 1123 4.5 685 3.7 435 <0.001
Diabetes          
 No 86.9 1280 90.4 1065 88.7 752 88.1 492 -
 Yes 13.1 889 9.6 836 11.3 503 11.9 466 0.008
Hypertension          
 No 70.1 1209 77.9 1111 75.4 757 73.0 498 -
 Yes 29.9 1275 22.1 806 24.6 622 27.0 465 <0.001
  1. Mean: Average of survival days.
  2. COPD: chronic obstructive pulmonary disease.
  3. Missing data: 16 cases.